Caterina Mancarella

Bologna, 40136, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Targeting IGF2BP3 in Cancer: From Molecular Structure and Biology to Early Drug Discovery.

Targeting IGF2BP3 in Cancer: From Molecular Structure and Biology to Early Drug Discovery.

Journal: International journal of molecular sciences

Published: June 05, 2026

Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcoma.

Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcoma.

Journal: Scientific reports

Published: February 24, 2026

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.

EphA2 in Cancer: Molecular Complexity and Therapeutic Opportunities.

Journal: International journal of molecular sciences

Published: October 08, 2024

Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy.

Targeting EWS::FLI1 to Advance Ewing Sarcoma Therapy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 11, 2024

Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic Approaches.

Extracellular Interactors of the IGF System: Impact on Cancer Hallmarks and Therapeutic Approaches.

Journal: International journal of molecular sciences

Published: May 09, 2024

Editorial: RNA-binding proteins in cancer: advances in translational research.

Editorial: RNA-binding proteins in cancer: advances in translational research.

Journal: Frontiers in cell and developmental biology

Published: February 22, 2024

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles.

Journal: International journal of molecular sciences

Published: November 27, 2023

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas.

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas.

Journal: International journal of molecular sciences

Published: October 13, 2023

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.

Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells.

Journal: Cancer gene therapy

Published: February 27, 2023

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: November 09, 2022

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.

CIC-Rearranged Sarcomas: An Intriguing Entity That May Lead the Way to the Comprehension of More Common Cancers.

Journal: Cancers

Published: September 22, 2022

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: August 29, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026